Literature DB >> 8288311

Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.

R Appelberg1, I M Orme.   

Abstract

In this study we found that addition of a range of doses of interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha), or granulocyte-macrophage colony stimulating factor (GM-CSF) to cultures of bone marrow-derived murine macrophages infected with the 25291 strain of Mycobacterium avium gave rise to varying degrees of bacteriostasis. In contrast, similar treatment with interleukin-4 (IL-4) or IL-6 had no effect. However, when similar experiments with the former set of cytokines were performed using a panel of M. avium isolates, substantial isolate-to-isolate variation was observed. In cultures containing IFN-gamma, synthesis of substantial levels of reactive nitrogen intermediates was observed; however, neither these materials, nor reactive oxygen intermediates, were found to be responsible for observed bacteriostasis. In further experiments, in which the culture medium was supplemented with various concentrations of a weak acid or a weak base in order to influence the pH of macrophage intracellular compartments, it was found that the presence of the weak acid augmented the activity of IFN-gamma, whilst the weak base counteracted this effect. These data support the hypothesis, therefore, that the bacteriostatic effect of IFN-gamma against the growth of M. avium, rather than depending on reactive radical production, is mediated through acidification of the infected phagosome, perhaps through activation of proton pumps in the phagosomal membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288311      PMCID: PMC1422224     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

Review 1.  In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?

Authors:  D M Yajko
Journal:  Res Microbiol       Date:  1992-05       Impact factor: 3.992

Review 2.  Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.

Authors:  J J Ellner; M J Goldberger; D M Parenti
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

4.  Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.

Authors:  L E Bermudez; M Wu; M Petrofsky; L S Young
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

5.  Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.

Authors:  C R Horsburgh; J A Havlik; D A Ellis; E Kennedy; S A Fann; R E Dubois; S E Thompson
Journal:  Am Rev Respir Dis       Date:  1991-09

6.  Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factor.

Authors:  I M Orme; S K Furney; P S Skinner; A D Roberts; P J Brennan; D G Russell; H Shiratsuchi; J J Ellner; W Y Weiser
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

8.  Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes.

Authors:  H Shiratsuchi; J L Johnson; J J Ellner
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

9.  Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide.

Authors:  L E Bermudez
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

10.  Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.

Authors:  C Truffot-Pernot; B Ji; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more
  37 in total

Review 1.  Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?

Authors:  Rui Appelberg
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.

Authors:  T Hayashi; S P Rao; K Takabayashi; J H Van Uden; R S Kornbluth; S M Baird; M W Taylor; D A Carson; A Catanzaro; E Raz
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors:  P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

4.  Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III).

Authors:  S J Gebran; Y Yamamoto; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.

Authors:  R Appelberg; A Sarmento; A G Castro
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion.

Authors:  Tânia Regina Marques Da Silva; Juliana Ribeiro De Freitas; Queilan Chagas Silva; Cláudio Pereira Figueira; Eliana Roxo; Sylvia Cardoso Leão; Luiz Antônio Rodrigues De Freitas; Patrícia Sampaio Tavares Veras
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages.

Authors:  A M Sarmento; R Appelberg
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Mycobacteria-induced autoantibody production is associated with susceptibility to infection but not with host propensity to develop autoimmune disease.

Authors:  A Brás; A P Aguas
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 9.  Animal and cell-culture models for the study of mycobacterial infections and treatment.

Authors:  I M Orme; A D Roberts; S K Furney; P S Skinner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

10.  Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages.

Authors:  Martha Torres; Lakshmi Ramachandra; Roxana E Rojas; Karen Bobadilla; Jeremy Thomas; David H Canaday; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.